Cough Syrup Recall: Several African Countries Take Action Over Safety Issues
The recall of Johnson & Johnson’s children’s cough syrup in 2021 due to high levels of a toxic substance has prompted drug authorities in several African countries to take precautionary measures to protect public health.
Following Nigeria’s National Agency for Food and Drug Administration and Control’s (NAFDAC) warning about the presence of diethylene glycol, a potentially fatal substance, in the syrup, other countries such as Tanzania, Zimbabwe, Kenya, South Africa, and Rwanda have also recalled the product. This widespread recall underscores the seriousness of the health risks of consuming the contaminated syrup.
Diethylene glycol has been linked to the recent deaths of children in Cameroon and The Gambia, highlighting the urgent need to remove the affected product from the market to prevent further harm. The substance is known to cause adverse effects, including acute kidney injury, which can be life-threatening.
The recalled batch of Benylin pediatric syrup, manufactured in South Africa, bears batch number 329304. Expiration authorities in affected countries have urged consumers to check product labels and report any adverse effects associated with the syrup.
In response to the recall, Kenvue, the company that owns the Benylin Pediatric Syrup brand, has stated that it is collaborating with authorities and conducting its tests to address the issue. This proactive approach is essential for ensuring the safety and well-being of consumers and restoring public trust in the product.
Overall, the recall underscores the importance of stringent quality control measures in the manufacturing and distribution of pharmaceutical products. It also reminds us of the critical role that drug regulatory authorities play in safeguarding public health by promptly identifying and addressing potential safety concerns.
